European Society for Medical Oncology (ESMO) 2004
3rd ESMO Patient Seminar

This article has been archived.
Please use for reference only.

Ultima Vez Modificado: 25 de febrero del 2009

Share article


Imprima English

OncoLink Cancer Resource - TV

The 3rd European Society of Medical Oncology (ESMO) Patient Seminar took place at the Austria Center, Vienna, during the 29th ESMO Congress. Physicians and patients came together for this valuable conference concerning issues such as new developments in the field of cancer treatment, the importance of clinical trials, information and empowerment to cope with the challenges patients are confronted with and techniques which may be helpful in strengthening the physical, mental, spiritual and emotional needs of affected individuals. The following files are RealMedia files that need to be played using a RealMedia player.


Latest Developments: Advances in care and follow-up of cancer patients

Introduction
Chairperson, Paris A. Kosmidis

Latest developments in breast cancer
Beat Thuerlimann

Latest developments in colorectal cancer
Jim Cassidy

Latest developments in lung cancer
Robert Pirker

Latest developments in prostate cancer
Othmar Zechner

Latest developments in breast cancer research: Patient advocacy and TransBIG
Susan Knox


Psycho-social issues in cancer: How to cope

Early diagnosis and follow-up, (patients's viewpoint)
Stephen Ward

Early diagnosis and follow-up, (psycho onclogist's viewpoint)
Ana Fernandez Marcos

Disease recurrence (patient)
Martin Thurnher

Disease recurrence and terminal phase (psychologist)
Ana Koutroubas


Family Issues

Scandinavia
Randi Persson

Southern Europe
Helen Kosmidis

Western and central Europe
Christian Ligensa

Eastern Europe
Kristi Luksep

Bringing it all together: The social worker's perspective
Tom Hudson


Working lives: The recognition of needs

Working Lives
Kathy Redmond


Understanding clinical trials

Understanding Clinical Trials
Louis Denis


Health in body and mind

Health in body and mind
Gillian Crosby


ESMO Concert

ESMO Concert

Imprima English
News
ESMO: Herceptin Best for HER2+ Breast Cancer Patients

Oct 1, 2014 - Trastuzumab (Herceptin) is the best drug treatment for human epidermal growth factor receptor 2-positive breast cancer and should remain the standard of care for that type of tumor, according to new research scheduled for presentation at the annual meeting of the European Society of Medical Oncology, held from Sept. 26 to 30 in Madrid.



OncoLink Treatment Binder

Seleccione los efectos secundarios y formas de ligante de tratamiento de su paciente

Más información



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información